Red Yeast Rice and Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02257047

Enrollment

120

Registered

2014-10-06

Start date

2014-10-31

Completion date

2019-03-31

Last updated

2017-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

To evaluate the effect of red yeast rice on subclinical atherosclerosis in patients with rheumatoid arthritis

Interventions

DIETARY_SUPPLEMENTTea

DIETARY_SUPPLEMENTRYR

red yeast rice

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* patients with a definite diagnose of rheumatoid arthritis(RA) were included if they met the classification criteria for RA established by the American Rheumatism Association (ACR) and European League Against Rheumatism (EULAR) in 2010 * aged from 18 to 75 years * without conflict to the written, informed consent signed prior to the enrollment * no severe hepatic or renal disorders * no known carotid artery stenosis * no coagulation disorders * no hypertension

Exclusion criteria

* being in pregnancy, lactation period or under a pregnancy plan * being allergic to the test drug * not compatible for the trial medication * without full legal capacity

Design outcomes

Primary

Measure	Time frame
Changes from baseline in Carotid intima-media thickness at 24 weeks	At 0 week, 12 weeks, 24 weeks

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026